This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Impax Laboratories, Inc.
Drug Names(s): FE159
Description: IPX159 is a new molecular entity in the US. It is an oral controlled-release formulation of a small molecule with a unique mechanism of action in Restless Leg Syndrome. IPX159 inhibits the uptake of neurotransmitters.
Pink Sheet ‘Complete Response’ Letters
Additional information available to subscribers only: